Attached files

file filename
EX-10.1 - EX-10.1 - IASIS Healthcare LLCd789410dex101.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 17, 2014 (September 12, 2014)

 

 

IASIS HEALTHCARE LLC

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   333-117362   20-1150104

(State or other jurisdiction

of organization)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

117 Seaboard Lane, Building E

Franklin, Tennessee

  37067
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: (615) 844-2747

Not Applicable

(Former name or former address, if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 1.01 — Entry into a Material Definitive Agreement.

On September 12, 2014, IASIS Healthcare LLC (“IASIS” or the “Company”) entered into an amendment (“Amendment No. 2”) to its Amended and Restated Credit Agreement dated as of May 3, 2011, as amended by Amendment No. 1 on February 20, 2013, among the Company, IASIS Healthcare Corporation, Bank of America, N.A., as administrative agent, collateral agent, L/C issuer and swing line lender and the lenders party thereto. Amendment No. 2, among other things, provides for an additional 365 days for the Company to reinvest the proceeds from certain asset sales.

The foregoing summary does not purport to be complete and is qualified in its entirety by reference to Amendment No. 2, attached hereto as Exhibit 10.1 and incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

 

Exhibit

Number

  

Exhibit

10.1    Amendment No. 2, dated as of September 12, 2014, among IASIS Healthcare LLC, IASIS Healthcare Corporation, Bank of America, N.A., as administrative agent, collateral agent, L/C issuer and swing line lender and the lenders party thereto.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

IASIS HEALTHCARE LLC
By:  

/s/ John M. Doyle

  John M. Doyle
  Chief Financial Officer

Date: September 17, 2014


EXHIBIT INDEX

 

Exhibit

Number

  

Description

10.1    Amendment No. 2, dated as of September 12, 2014, among IASIS Healthcare LLC, IASIS Healthcare Corporation, Bank of America, N.A., as administrative agent, collateral agent, L/C issuer and swing line lender and the lenders party thereto.